Cargando…
Nanosomal docetaxel lipid suspension based chemotherapy in a pregnant MBC patient – a case report
The current report presents a case of a pregnant woman with breast cancer metastasized to liver and lungs. The standard of care for breast cancer in pregnancy is anthracycline/taxane-based chemotherapy regimens. Docetaxel has shown a favorable toxicity profile during the second and third trimesters...
Autores principales: | Ramaswamy, Rajkumar, Joshi, Nisarg, Khan, Mujtaba A, Siddhara, Seerin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642620/ https://www.ncbi.nlm.nih.gov/pubmed/31406465 http://dx.doi.org/10.2147/OTT.S206573 |
Ejemplares similares
-
Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study
por: Subramanian, Sundaram, et al.
Publicado: (2020) -
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study
por: Narayanan, Prasad, et al.
Publicado: (2019) -
Efficacy and safety of nanosomal docetaxel lipid suspension-based chemotherapy in squamous cell carcinoma of the head and neck: A multicenter retrospective study
por: Kumar Das Majumdar, Saroj, et al.
Publicado: (2020) -
A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer
por: Samar, Aseem, et al.
Publicado: (2020) -
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
por: Badiginchala, Revathi, et al.
Publicado: (2023)